AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
ID: 353125Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353125

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-165.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity for the establishment of AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional). This initiative aims to enhance research infrastructure and promote interdisciplinary studies that address the intersection of mental health and HIV/AIDS, with a focus on innovative research in areas such as biostatistics, prevention, and implementation science, while prioritizing health disparities and systemic inequities in HIV care. Eligible applicants, including educational institutions, non-profits, and local governments with substantial research capacity, can apply for grants with a budget cap of $1.5 million annually for up to five years, with the submission opening on July 25, 2024, and various review cycles extending through 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-165.html
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), issued a Notice of Funding Opportunity (NOFO) focused on the AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional). This initiative aims to establish HIV/AIDS Research Centers (ARCs) that enhance research infrastructure and promote interdisciplinary studies addressing the intersection of mental health and HIV/AIDS. The centers will concentrate on innovative research in various domains including biostatistics, prevention, and implementation science, with priority given to addressing health disparities and systemic inequities in HIV care. Applications are invited for new, renewal, or resubmission grants with a budget cap of $1.5 million annually for up to five years. Eligible applicants include educational institutions, non-profits, and local governments that can demonstrate substantial research capacity. Key dates include a submission opening on July 25, 2024, with various review cycles extending through 2027. Additionally, applicants must follow specific guidelines for submission and data management, including sharing outcomes through the NIMH Data Archive. This funding opportunity seeks to foster collaboration across sectors and enhance the impact of HIV research while aligning with national strategies for HIV prevention and care. The overall aim is to build robust capabilities that drive forward the understanding and treatment of HIV/AIDS.
    Similar Opportunities
    Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for Center Core Grants (P30) to establish Developmental AIDS Research Centers (D-ARC) focused on advancing research in mental health and HIV/AIDS. The program aims to support high-impact, interdisciplinary research across various domains, including NeuroHIV, behavioral science, and implementation science, while providing essential infrastructure to foster innovation and collaboration in HIV prevention and treatment strategies. Eligible applicants may request budgets up to $750,000 per year for a maximum of four years, with a strong encouragement for entities from underrepresented backgrounds to apply. The earliest application date is July 25, 2024, with final proposals due by 5 PM local time on August 25, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Centers for AIDS Research (CFAR) program, aimed at enhancing interdisciplinary HIV/AIDS research through grants. This initiative seeks to provide administrative and shared research support, fostering collaboration and infrastructure at institutions with significant NIH-funded research bases. CFARs are expected to deliver core facilities and expertise, promoting diversity, equity, and inclusion among researchers while addressing the global HIV/AIDS epidemic. Interested applicants must submit their proposals by August 4, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services," aimed at supporting innovative research in integrated care models for HIV/AIDS and substance use disorders. The initiative seeks to improve health outcomes and enhance care coordination for individuals at heightened risk by addressing service delivery gaps through collaborative and evidence-based practices. This grant, with a funding ceiling of $450,000 over three years, is open to a diverse range of eligible applicants, including higher education institutions and community-based organizations, with applications due by March 19, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-020.html.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the funding opportunity titled "Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)" under the National Institute of Mental Health (NIMH). This initiative aims to support innovative research focused on optimizing HIV prevention and care, emphasizing the understanding of behavioral and social science factors that influence the HIV continuum, including intervention efficacy trials and implementation science studies. The program is critical for advancing national efforts to address HIV effectively, promoting community engagement and multidisciplinary collaboration to achieve equitable health outcomes for diverse populations. Interested applicants can find more information and application details at the provided link, with a submission deadline of January 9, 2026, and no cost-sharing or matching requirements.
    Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders" through the R01 Research Project Grant. This initiative aims to support innovative and high-risk studies that explore the molecular mechanisms linking HIV and substance use disorders (SUDs), with a focus on advancing understanding of HIV dynamics within the Central Nervous System (CNS). The total estimated program funding is $2 million for fiscal year 2026, with the potential to support up to three awards, and applications must include clear milestones and human or primate studies. Interested applicants should note that the deadline for submitting letters of intent and applications is July 14, 2025, and no clinical trials are permitted under this grant. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)." This initiative aims to support multilevel and multidisciplinary intervention research focused on improving the quality of life and promoting successful aging among individuals living with HIV, particularly those from racial and ethnic minority groups and lower socioeconomic backgrounds. The funding, which ranges from $5-6 million to support approximately 5-6 awards, will provide a maximum budget of $750,000 annually over five years for projects that address social determinants of health and involve community engagement. Interested applicants can find more details and guidelines on the NIH website, with the application process opening on November 11, 2023, and a submission deadline of December 12, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)" to stimulate research aligned with the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative aims to support research on HIV-related comorbidities, gastrointestinal diseases, and metabolic disorders associated with HIV, encouraging applications from a diverse range of organizations, including higher education institutions and non-profits. With an estimated funding of $2 million for fiscal year 2025, the NIH plans to support 3 to 5 selected projects over a maximum project period of five years, with applications undergoing a rigorous peer review process. Interested applicants can find more information and submit their proposals through Grants.gov, with a submission deadline of January 7, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for the Developmental Centers for AIDS Research (D-CFAR) program, aimed at enhancing HIV/AIDS research through administrative support and shared resources. This initiative invites applications from eligible institutions to establish D-CFARs that will foster interdisciplinary collaboration and address gaps in research infrastructure, with a focus on supporting early career investigators. Each institution may submit one application, with potential awards totaling up to $1 million annually for a duration of five years, and applications are due by August 4, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-117.html.